Eltroxin 125mcg Tablet is indicated for the management of hypothyroidism, a condition where the thyroid gland fails to produce an adequate amount of thyroid hormones. This medication serves to supplement the deficient hormone levels, promoting more effective regulation of your body’s metabolism and energy levels. Prior to initiating treatment with Eltroxin, it is essential for your healthcare provider to conduct a blood test to establish the appropriate dosage tailored to your individual needs. Following the commencement of therapy, you will undergo periodic blood tests to monitor the medication’s efficacy and to make any necessary dosage adjustments. It is recommended to take this medication on an empty stomach, ideally before the first meal of the day, and adherence to the prescribed regimen is crucial for achieving optimal therapeutic outcomes. Improvements in symptoms may not be immediately noticeable and could take several weeks to manifest. This medication may need to be taken indefinitely, as discontinuation could result in the return of symptoms. Some individuals may experience side effects if the dosage exceeds their requirement, such as palpitations, vomiting, anxiety, diarrhea, weight loss, tremors, increased appetite, and restlessness. Most of these adverse effects tend to resolve once the dosage is appropriately calibrated. In the event of severe symptoms like high fever, rapid or irregular heartbeat, hypotension, jaundice, confusion, or seizures, immediate medical attention is necessary. It is important to note that while Eltroxin may contribute to weight loss, it is not intended for the treatment of obesity. Additionally, if pregnancy occurs while on this medication, it is imperative to consult a healthcare provider as dosage modifications may be necessary. Be sure to discuss any other medications you are using, as they may interact with Eltroxin.
-14%

ELTROXIN 125MCG (Thyroxine (125mcg))
Original price was: ₹107.00.₹92.00Current price is: ₹92.00.
Add to cart
Buy Now



Reviews
There are no reviews yet.